Joe Rayne
Investor Relations Contact chez NUVATION BIO INC.
Profil
Joe Rayne is currently working as an Investor Relations Contact at Nuvation Bio, Inc. Previously, he worked as the Head-Investor Relations at Inotek Pharmaceuticals Corp.
and as a Vice President at Argot Partners LLC from 2017 to 2021.
Postes actifs de Joe Rayne
| Sociétés | Poste | Début |
|---|---|---|
| NUVATION BIO INC. | Investor Relations Contact | - |
Anciens postes connus de Joe Rayne
| Sociétés | Poste | Fin |
|---|---|---|
Argot Partners LLC
 Argot Partners LLC Miscellaneous Commercial ServicesCommercial Services Part of Danforth Advisors LLC, Argot Partners LLC is a strategic communications consultancy exclusively focused on the life sciences. The company is based in New York, NY, with offices in the Boston area. The company provides a broad suite of services to over 90 clients across all stages of their corporate evolution. The company's services include corporate communications and investor relations, public relations and digital media, IPO, data, partnership, product approval, commercial launch, M&A, and special situations communications, executive visibility and training, ESG communications, event planning, and a full suite of creative services. The company was founded in 2007 by David M.F. Pitts, Andrea F. Rabney. Andrea F. Rabney has been the CEO since 2007. Argot Partners was acquired by Danforth Advisors LLC on January 04, 2023. | Corporate Officer/Principal | 01/08/2021 |
Inotek Pharmaceuticals Corp.
 Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | Investor Relations Contact | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NUVATION BIO INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | Health Technology |
Argot Partners LLC
Argot Partners LLC Miscellaneous Commercial ServicesCommercial Services Part of Danforth Advisors LLC, Argot Partners LLC is a strategic communications consultancy exclusively focused on the life sciences. The company is based in New York, NY, with offices in the Boston area. The company provides a broad suite of services to over 90 clients across all stages of their corporate evolution. The company's services include corporate communications and investor relations, public relations and digital media, IPO, data, partnership, product approval, commercial launch, M&A, and special situations communications, executive visibility and training, ESG communications, event planning, and a full suite of creative services. The company was founded in 2007 by David M.F. Pitts, Andrea F. Rabney. Andrea F. Rabney has been the CEO since 2007. Argot Partners was acquired by Danforth Advisors LLC on January 04, 2023. | Commercial Services |